Log In
BCIQ
Print this Print this
 

Beta amyloid

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Beta amyloid

BCIQ
Print ChartPrint this
Marketed, 2 Approved, 1 Phase III, 4 Phase III, 1 Phase II, 1 Phase II, 8 Phase II, 1 Phase I, 6 Pilot, 2 Preclinical, 1 Preclinical, 9 Preclinical, 1 Discovery, 2
Phase of DevelopmentDiscoveryPreclinicalPilotPhase IPhase IIPhase IIIApprovedMarketed
Diagnostic

-

1

2

-

1

1

1

2

Neurology

2

9

-

6

8

4

-

-

Ophthalmic

-

1

-

-

1

-

-

-




 Products Targeting Beta amyloid
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

24

$11,709.5M

$3,814.8M

$677.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today